blood cancer
Coverage of blood cancer in the Nexus archive.
- STAT+: FDA approves Orca Bio’s T cell therapy for blood cancer patients
The FDA approved Orca Bio's T cell therapy, Tregzi, which reduces immune reaction risks for blood cancer patients undergoing stem cell transplants. The therapy offers a curative alternative to traditional transplants that carry high risks of chronic graft-versus-host disease.
- Taskmaster star Richard Herring, 58, reveals he has been diagnosed with a very rare blood cancer as he shares health update four years after getting the all-clear from the disease
Taskmaster star Richard Herring, 58, has been diagnosed with a rare blood cancer. This comes four years after he received the all-clear from the disease.
- Nonprofit buys experimental cancer drug to maintain patient access
Nonprofit Blood Cancer United acquired discontinued experimental cancer drug Luvelta to maintain patient access, managing a compassionate-use program for children with a rare blood cancer and distributing the medication at no cost while supplies last.
- Wellness coach, 40, dies after ‘detox’ ritual involving ‘toad vaccine’ — months after beating cancer
Wellness coach Kristian Trend, 40, died after participating in a 'toad vaccine' detox ritual months after recovering from aggressive blood cancer. He had previously overcome the disease but succumbed to complications from the holistic wellness practice.
- Long-lived immune cells show promise against cancer in world-first trial
A world-first clinical trial using long-lived T cells that mimic stem cells achieved remission in some blood cancer patients. The study, published in Nature on April 30, 2026, highlights a promising new approach to cancer immunotherapy.